SAN DIEGO, May 24, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced the presentation of two posters related to the company’s Targeted ...
Denver, CO, April 16, 2026 (GLOBE NEWSWIRE)-- Palisade Bio, Inc. (Nasdaq: PALI) ("Palisade” or the "Company”), a clinical-stage biopharmaceutical company developing next-generation, once-daily, oral ...
GUILFORD, Conn., March 17, 2022 (GLOBE NEWSWIRE) -- Invea Therapeutics, Inc., a global leader in applying Artificial Intelligence (AI) and Machine Learning (ML) to transform drug discovery and ...
SPY001 is a novel, half-life extended α4β7 antibody in development for the treatment of Inflammatory Bowel Disease (IBD) SPY001 pharmacokinetic (PK) data up to eight months continues to support a ...
Anatomy education in 2026 is shifting from siloed memorization to integrated systems thinking, where the digestive system serves as the perfect anchor to connect joint mobility, epithelial barriers, ...
Poster presentation scheduled for Tuesday, May 5th at 12:30 PM CDT Denver, CO, April 16, 2026 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results